Search Results
Results found for "Neel Freedman"
- GPCR Pharmacology Insights That Prevent Real Drug Discovery Failures
Kenakin reveals the substrate strategy needed for credible DDI assessment. Why Terry’s Corner Give You The GPCR Pharmacology Insights You Need Terry’s Corner gives discovery scientists
- G-protein-coupled receptors as therapeutic targets for glioblastoma
of life during treatment coupled with brain tumour recurrence; thus, new treatments are desperately needed
- TRPM3 in the eye and in the nervous system - from new findings to novel mechanisms
However, a clear picture is needed to unravel TRPM3's full potential as experimental tool, diagnostic
- All About Addgene: More Open and Reproducible Science with Materials Sharing
If you need a plasmid for your research or you want to share your materials, this is the place to go.
- Pharmacophore-guided Virtual Screening to Identify New β 3 -adrenergic Receptor Agonists
Hence, new β3 -AR agonists are needed as starting points for drug development.
- In vitro assays for the functional characterization of (psychedelic) substances at the serotonin...
variety, leading to insufficiently described structure-activity relationships, hence illustrating the need
- Effect Delta-9-tetrahydrocannabinol and cannabidiol on milk proteins and lipid levels in HC11 cells
However, the increasing rate of cannabis use among pregnant women has presented an urgent need to investigate
- Using Live-cell High-Content Screening to Characterize CB2 Ligands: Insights From 16 Synthetic Cannabinoids
and non-specific interactions introduce noise at precisely the stage where medicinal chemistry teams need physiologically grounded triage of ligand candidates—exactly the type of early clarity medicinal chemistry teams need
- High-Content Screening for GPCR Programs: Overcoming Assay Limitations with Fluorescent Ligands
Why Traditional Radioligand Methods Fall Short for Modern Screening Needs Radioligand binding assays provided as a complete CB2 HCS service—allowing teams to integrate fluorescent ligand technologies without needing
- AlphaFold’s Breakthrough in GPCR Research: Revolutionizing Discovery, Yet Awaiting Experimental Proof
AlphaFold2 uses an AI-driven approach that eliminates the need for structural templates, allowing it
- Opposite Effects of Src Family Kinases on YAP and ERK Activation in Pancreatic Cancer Cells...
therapeutic options are limited, novel targets and agents for therapeutic intervention are urgently needed
- Target Residence Time: The Hidden Driver of In Vivo Efficacy
diffusion to PK–PD dissociation, Kenakin equips you with the kinetic models and biological context needed
- Asking Better Questions in Science: A Practical Guide for Emerging Researchers
That first sentence is often the only barrier between you and the insight you need.
- From Pipettes to Platforms: The Evolution of GPCR Research
The GPCR field needs thinkers who can direct platforms, not just operate them.
- How GPCR Spatial Signaling Sparked a Scientific Journey
For Early-Career Scientists: Your pivotal moment might not feel like fireworks.
- Applications of Fluorescent Probes in Confocal Imaging of GPCRs: From Live to Fixed Cells
, our GPCR fluorescent ligands are designed with a variety of photophysical properties to meet your needs
- Why “Displacement” Misleads You: Allosteric Binding Demystified
Thermodynamics > Intuition: Why the Hall Cube Matters To untangle complex binding behaviors, you need
- Differential binding of Δ9-tetrahydrocannabinol derivatives to type 1 cannabinoid receptors (CB1)
If you are interested in our ligands or technology, feel free to contact me anytime. References 1.
- GPCR Allosteric Modulation: Why Allostery is the Engine of Drug Discovery
efficacy, selectivity, and SAR interpretation ✅ Insight into cryptic binding sites and why some drugs need
- 🎄 Have Yourself a Merry Little GPCRmas! ❄ Dec 9 - 15, 2024
Your feedback will guide us in tailoring resources , tools , and content to meet your needs better and
- Activation of GPR183 by 7 α,25-Dihydroxycholesterol Induces Behavioral Hypersensitivity through...
Further investigation of the signaling pathways downstream of GPR183 is needed to support the development
- Role of G Protein-Coupled Receptors in Hepatic Stellate Cells and Approaches to Anti-Fibrotic ...
events in non-alcoholic steatohepatitis (NASH), an advanced form of NAFLD, is currently an unmet medical need
- A robust and Efficient FRET-Based Assay for Cannabinoid Receptor Ligands Discovery.
agents.[1–3] These insights highlight the potential in modulating the ECS to fulfill unmet medical needs potency in the CB1R. [9,10] 1.2 Novel fluorescent strategies for CBR binding affinity assays Thus, the need If you have any questions about CELT-335 or the assays themselves, feel free to contact me!
- 📰 GPCR Weekly News, October 2 to 8, 2023
No registration is needed to submit your logo design. Subscribe now to Dr.
- Involvement of various chemokine/chemokine receptor axes in trafficking and oriented locomotion ...
Thus, the development of novel and safe medications needs to be considered for the disease management
- How Schild Analysis Protects Your Conclusions in GPCR Research
GPCR scientists, translational pharmacologists, biotech discovery teams, and decision-makers who need
- How Breakthroughs Happen: Eric Trinquet on Innovation, Serendipity & GPCRs
It began with an unmet need: how to track Gq-coupled GPCR activity without the mess of calcium flux or
- Purpose-Driven Opioid Research: Catherine Demery’s Academic Path
It makes the work feel urgent.”
- 📰 GPCR Weekly News, October 9 to 15, 2023
No registration is needed to submit your logo design. Subscribe to Dr.
- 📰 GPCR Weekly News, June 12 to 18, 2023
Confo Therapeutics and AbCellera partner on GPCR-targeting antibodies GPCR Inhibition With ICB May Be Needed

















